Skip to main content

Table 3 Biochemical parameters and clinical characteristics of adult patients with type 2 diabetes mellitus on follow up at the diabetic clinic of Jimma University medical center, south-west Ethiopia, April 01–June 30, 2017

From: Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study

Variables

Cases, N (%)

Controls, N (%)

Total, N (%)

Total cholesterol

 < 200 mg/dL

45 (58.40)

65 (81.30)

110)70.10)

 ≥ 200 mg/dL

32 (41.60)

15 (18.80)

47 (29.90)

Triglyceride

 < 150

43 (58.10)

49 (64.50)

92 (61.30)

 ≥ 150

31 (41.90)

27 (35.50)

58 (38.70)

HDL

 M: ≥40 mg/Dl, F:≥50 mg/dL

44 (60.30)

42 (55.30)

86 (57.70)

 M:< 40 mg/dL, F:< 50 mg/dL

29 (39.70)

34 (44.70)

63 (42.30)

LDL

 < 100 mg/dL

53 (68.80)

60 (76.90)

113 (72.90)

 ≥ 100 mg/dL

24 (31.20)

18 (23.10)

42 (27.10)

BMI

 < 25

131 (63.90)

129 (62.90)

260 (63.40)

 25–29.99

56 (27.30)

60 (29.30)

116 (28.30)

 ≥ 30

18 (8.80)

16 (7.80)

34 (8.30)

Waist to hip ratio

 M:< 0.9, F:< 0.85

20 (9.80)

64 (31.20)

84 (20.50)

 M: ≥0.9, F: ≥0.85

185 (90.20)

141 (68.80)

326 (79.50)

Duration

 ≤ 7 years

98 (47.80)

141 (68.80)

239 (58.30)

 > 7 years

107 (52.20)

64 (31.20)

171 (41.70)

Types of antidiabetes medication

 Glibenclimide alone

4 (2.00)

3 (1.50)

7 (1.71)

 Metformin+Glibenclimide

74 (36.10)

49 (23.90)

123 (30.00)

 Insulin alone

65 (31.70)

64 (31.20)

129 (31.46)

 Metformin + Insulin

33 (16.10)

28 (13.70)

61 (14.88)

 Metformin alone

29 (14.10)

61 (29.80)

90 (21.95)

Polypharmacy

 Yes

49 (23.90)

21 (10.20)

70 (17.10)

 No

156 (76.10)

184 (89.80)

340 (82.90)